IRONWOOD PHARMACEUTICALS, INC. Amortization of Debt Issuance Costs and Discounts
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Amortization of Debt Issuance Costs and Discounts of $1.90 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2025-03-31
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-12-31 was $415.00K, a 29.30% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-09-30 was $350.00K, a 40.27% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-06-30 was $550.00K, a 13.40% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-03-31 was $589.00K, a 46.52% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $1.90M, a 7.57% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $2.06M, a 11.17% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $1.85M, a 92.26% decline from fiscal 2021.
- IRONWOOD PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2021 was $23.93M, a 7.51% increase from fiscal 2020.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2024-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $765.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.31M derived: sum of 3 quarters · filed 2025-03-31 | $1.90M 10-K · filed 2025-03-31 |
| 2024-09-30 | $350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $900.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.49M 10-Q · filed 2024-11-07 | $2.08M derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | $550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.14M 10-Q · filed 2024-08-08 | $1.73M derived: sum of 3 quarters · filed 2025-03-31 | $2.31M derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-03-31 | $589.00K 10-Q · filed 2024-05-09 | $1.18M derived: sum of 2 quarters · filed 2025-03-31 | $1.76M derived: sum of 3 quarters · filed 2025-03-31 | $2.25M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.17M derived: sum of 2 quarters · filed 2025-03-31 | $1.66M derived: sum of 3 quarters · filed 2025-03-31 | $2.06M 10-K · filed 2025-03-31 |
| 2023-09-30 | $586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.07M derived: sum of 2 quarters · filed 2024-11-07 | $1.47M 10-Q · filed 2024-11-07 | $1.87M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $887.00K 10-Q · filed 2024-08-08 | $1.29M derived: sum of 3 quarters · filed 2025-03-31 | $1.69M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | $402.00K 10-Q · filed 2024-05-09 | $802.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.20M derived: sum of 3 quarters · filed 2025-03-31 | $1.72M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $800.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.32M derived: sum of 3 quarters · filed 2025-03-31 | $1.85M 10-K · filed 2025-03-31 |
| 2022-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $916.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.45M 10-Q · filed 2023-11-09 | $7.60M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.05M 10-Q · filed 2023-08-09 | $7.20M derived: sum of 3 quarters · filed 2024-02-16 | $13.24M derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $537.00K 10-Q · filed 2023-05-04 | $6.68M derived: sum of 2 quarters · filed 2024-02-16 | $12.72M derived: sum of 3 quarters · filed 2024-02-16 | $18.65M derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $6.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $12.19M derived: sum of 2 quarters · filed 2024-02-16 | $18.11M derived: sum of 3 quarters · filed 2024-02-16 | $23.93M 10-K · filed 2024-02-16 |
| 2021-09-30 | $6.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $11.96M derived: sum of 2 quarters · filed 2022-11-03 | $17.79M 10-Q · filed 2022-11-03 | $23.50M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $5.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $11.75M 10-Q · filed 2022-08-04 | $17.47M derived: sum of 3 quarters · filed 2023-02-16 | $23.08M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $5.82M 10-Q · filed 2022-05-05 | $11.54M derived: sum of 2 quarters · filed 2023-02-16 | $17.16M derived: sum of 3 quarters · filed 2023-02-16 | $22.67M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $11.33M derived: sum of 2 quarters · filed 2023-02-16 | $16.85M derived: sum of 3 quarters · filed 2023-02-16 | $22.26M 10-K · filed 2023-02-16 |
| 2020-09-30 | $5.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $11.13M derived: sum of 2 quarters · filed 2021-11-04 | $16.55M 10-Q · filed 2021-11-04 | $20.60M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $5.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $10.93M 10-Q · filed 2021-08-05 | $14.99M derived: sum of 3 quarters · filed 2022-02-18 | $21.22M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $5.42M 10-Q · filed 2021-05-06 | $9.47M derived: sum of 2 quarters · filed 2022-02-18 | $15.71M derived: sum of 3 quarters · filed 2022-02-18 | $20.40M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $10.29M derived: sum of 2 quarters · filed 2022-02-18 | $14.98M derived: sum of 3 quarters · filed 2022-02-18 | $19.59M 10-K · filed 2022-02-18 |
| 2019-09-30 | $6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.92M derived: sum of 2 quarters · filed 2020-11-05 | $15.53M 10-Q · filed 2020-11-05 | $20.09M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-06-30 | $4.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $9.30M 10-Q · filed 2020-08-06 | $13.86M derived: sum of 3 quarters · filed 2021-02-17 | $18.31M derived: sum of 4 quarters · filed 2021-02-17 |
| 2019-03-31 | $4.61M 10-Q · filed 2020-05-06 | $9.17M derived: sum of 2 quarters · filed 2021-02-17 | $13.62M derived: sum of 3 quarters · filed 2021-02-17 | $17.97M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $9.01M derived: sum of 2 quarters · filed 2021-02-17 | $13.36M derived: sum of 3 quarters · filed 2021-02-17 | $17.60M 10-K · filed 2021-02-17 |
| 2018-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $8.80M derived: sum of 2 quarters · filed 2019-10-31 | $13.04M 10-Q · filed 2019-10-31 | $17.21M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $8.59M 10-Q · filed 2019-07-30 | $12.75M derived: sum of 3 quarters · filed 2020-02-13 | $16.82M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $4.24M 10-Q · filed 2019-05-02 | $8.40M derived: sum of 2 quarters · filed 2020-02-13 | $12.47M derived: sum of 3 quarters · filed 2020-02-13 | $16.44M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $8.23M derived: sum of 2 quarters · filed 2020-02-13 | $12.20M derived: sum of 3 quarters · filed 2020-02-13 | $16.08M 10-K · filed 2020-02-13 |
| 2017-09-30 | $4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $8.04M derived: sum of 2 quarters · filed 2018-11-06 | $11.92M 10-Q · filed 2018-11-06 | $15.75M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $7.85M 10-Q · filed 2018-08-06 | $11.68M derived: sum of 3 quarters · filed 2019-02-25 | $15.44M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $3.88M 10-Q · filed 2018-05-04 | $7.71M derived: sum of 2 quarters · filed 2019-02-25 | $11.47M derived: sum of 3 quarters · filed 2019-02-25 | $15.12M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $7.59M derived: sum of 2 quarters · filed 2019-02-25 | $11.24M derived: sum of 3 quarters · filed 2019-02-25 | $14.81M 10-K · filed 2019-02-25 |
| 2016-09-30 | $3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $7.41M derived: sum of 2 quarters · filed 2017-11-02 | $10.98M 10-Q · filed 2017-11-02 | $14.48M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $3.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $7.22M 10-Q · filed 2017-08-03 | $10.72M derived: sum of 3 quarters · filed 2018-02-22 | $14.15M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $3.57M 10-Q · filed 2017-05-08 | $7.08M derived: sum of 2 quarters · filed 2018-02-22 | $10.50M derived: sum of 3 quarters · filed 2018-02-22 | $11.30M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $6.93M derived: sum of 2 quarters · filed 2018-02-22 | $7.73M derived: sum of 3 quarters · filed 2018-02-22 | $8.10M 10-K · filed 2018-02-22 |
| 2015-09-30 | $3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $4.23M derived: sum of 2 quarters · filed 2016-11-07 | $4.60M 10-Q · filed 2016-11-07 | $4.96M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.17M 10-Q · filed 2016-08-08 | $1.53M derived: sum of 3 quarters · filed 2017-02-22 | $1.95M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $370.00K 10-Q · filed 2016-05-10 | $735.00K derived: sum of 2 quarters · filed 2017-02-22 | $1.15M derived: sum of 3 quarters · filed 2017-02-22 | $1.55M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $778.00K derived: sum of 2 quarters · filed 2017-02-22 | $1.18M derived: sum of 3 quarters · filed 2017-02-22 | $1.57M 10-K · filed 2017-02-22 |
| 2014-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $815.00K derived: sum of 2 quarters · filed 2015-11-05 | $1.20M 10-Q · filed 2015-11-05 | $1.60M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $788.00K 10-Q · filed 2015-08-07 | $1.18M derived: sum of 3 quarters · filed 2016-02-19 | $1.57M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $386.00K 10-Q · filed 2015-05-06 | $781.00K derived: sum of 2 quarters · filed 2016-02-19 | $1.17M derived: sum of 3 quarters · filed 2016-02-19 | $1.65M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $782.00K derived: sum of 2 quarters · filed 2016-02-19 | $1.27M derived: sum of 3 quarters · filed 2016-02-19 | $1.72M 10-K · filed 2016-02-19 |
| 2013-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $871.00K derived: sum of 2 quarters · filed 2014-11-05 | $1.32M 10-Q · filed 2014-11-05 | |
| 2013-06-30 | $484.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $937.00K 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | $453.00K 10-Q · filed 2014-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |